A5066232987- Bladder and Urothelial Cancer Treatments
- Urinary and Genital Oncology Studies
- Renal cell carcinoma treatment
- Esophageal Cancer Research and Treatment
- Social Media in Health Education
- Health Literacy and Information Accessibility
- Multiple and Secondary Primary Cancers
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
- Testicular diseases and treatments
- Pediatric Urology and Nephrology Studies
- Urologic and reproductive health conditions
- Urological Disorders and Treatments
- Economic and Financial Impacts of Cancer
- Misinformation and Its Impacts
- Colorectal Cancer Screening and Detection
- Global Cancer Incidence and Screening
- Genetic and Kidney Cyst Diseases
- Health Systems, Economic Evaluations, Quality of Life
- Renal and Vascular Pathologies
- Ureteral procedures and complications
- Patient-Provider Communication in Healthcare
- Sarcoma Diagnosis and Treatment
- Radiomics and Machine Learning in Medical Imaging
- Cancer Genomics and Diagnostics
The University of Texas Southwestern Medical Center
2022-2025
Southwestern Medical Center
2024
Brigham and Women's Hospital
2023
Harvard University
2023
Nuffield Orthopaedic Centre
2023
NYU Langone Health
2019-2022
New York University
2019-2021
VA NY Harbor Healthcare System
2021
Vanderbilt University Medical Center
2019
Manhattan Psychiatric Center
2019
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by authors. Any queries (other than missing content) should be directed to corresponding author article.
Non‐muscle‐invasive bladder cancer (NMIBC) is the most common form of cancer, with frequent recurrences and risk progression. Risk‐stratified treatment surveillance protocols are often used to guide management. In 2017, BJUI reviewed guidelines on NMIBC from four major organizations: American Urological Association/Society Oncology, European Association Urology, National Comprehensive Cancer Network, Institute for Health Care Excellence. The present update will review changes in broadly...
Objective To quantify the oncological risks of bladder‐sparing therapy (BST) in patients with Bacillus Calmette–Guérin (BCG)‐unresponsive non‐muscle‐invasive bladder cancer (NMIBC) compared to upfront radical cystectomy (RC). Patients and Methods Pre‐specified data elements were collected from retrospective cohorts BCG‐unresponsive NMIBC 10 international sites. After Institutional Review Board approval, included if they had meeting United States Food Drug Administration criteria. Oncological...
The use of social media is rapidly expanding. This technology revolution changing the way healthcare providers share information with colleagues, patients, and other stakeholders. As increases in urology, maintaining a professional online identity interacting appropriately one's network are vital to engaging positively protecting patient health information. There many opportunities for collaboration exchange ideas, but pitfalls exist without adherence proper etiquette. purpose this article...
Objective To determine the oncological impact of extended pelvic lymph node dissection (ePLND) vs standard PLND (sPLND) during radical cystectomy (RC) in clinically node‐positive (cN+) bladder cancer (BCa). Patients and Methods In this retrospective, multicentre study we included 969 patients who underwent RC with sPLND (internal/external iliac obturator nodes) or ePLND (sPLND plus common presacral without platin‐based peri‐operative chemotherapy for cTany N1‐3 M0 BCa between 1991 2022. We...
Objective To investigate the optimal number of induction chemotherapy cycles needed to achieve a pathological response in patients with clinically lymph node‐positive (cN+) bladder cancer (BCa) who received three or four followed by consolidative radical cystectomy (RC) pelvic node dissection. Patients and Methods We included 388 cisplatin/gemcitabine (dose‐dense) methotrexate, vinblastine, doxorubicin, cisplatin (MVAC), RC for cTanyN1–3M0 BCa. compared complete (pCR = ypT0N0) objective (pOR...
It is well known that adipose tissue plays a key role in the metabolic syndrome. We investigated whether visceral fat (VFA) and or subcutaneous (SQF) levels are associated with tumor phenotype of small renal masses. Additionally, we sought to investigate relationship between VFA baseline function as measured by glomerular filtration rate.From 2002 through 2011, 144 patients undergoing minimally invasive partial nephrectomy were retrospectively reviewed radiologist for SQF measurements, using...
Objective To examine whether lifestyle factors, including sedentary time and physical activity, could independently contribute to risk of end-stage renal disease (ESRD). Study design Case-cohort study. Setting South-eastern USA. Participants The Southern Community Cohort recruited ~86 000 black white participants from 2002 2009. We assembled a case cohort 692 incident ESRD cases probability sample 4113 participants. Predictors Sedentary was calculated as hours/day daily sitting activities....